FindTrial
Sign In

Risk of Lymph Node Metastasis and Feasibility of Endoscopic Submucosal Dissection in Undifferentiated-type Early Gastric Cancer

Lymph node metastasis and applicability of endoscopic submucosal dissection in undifferentiated-type early gastric cancer: a single-center retrospective analysis of surgical cases

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200059841
Enrollment
Unknown
Registered
2022-05-12
Start date
2022-05-01
Completion date
Unknown
Last updated
2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Early gastric cancer

Interventions

None listed

Sponsors

The First Affiliated Hospital of Anhui Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Patients who underwent radical gastric cancer and lymph node dissection at the First Affiliated Hospital of Anhui Medical University between January 2014 and December 2021; 2. Postoperative undifferentiated early gastric cancer as initially diagnosed and reviewed by 2 pathologists; 3. Complete medical record.

Exclusion criteria

Exclusion criteria: 1. Preoperative neoadjuvant radiochemotherapy; 2. Remnant gastric cancer or recurrent cancer of the remnant stomach; 3. Other malignant tumors of the stomach such as gastrointestinal stromal tumors, lymphomas, neuroendocrine tumors; 4. Serious hematologic diseases and other diseases that may affect the study results.

Design outcomes

Primary

MeasureTime frame
Lymph node metastasis;—

Countries

China

Contacts

Public ContactYalei Wang

The First Affiliated Hospital of Anhui Medical University

alei416@163.com+86 13855119816

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 11, 2026